Change of Heart: the Epitranscriptome of Small Non-coding RNAs in Heart Failure

Tamar Woudenberg, Nyika D. Kruyt, Paul H.A. Quax, A. Yaël Nossent*

*Corresponding author for this work

Research output: Contribution to journalReviewpeer-review

5 Citations (Scopus)

Abstract

Purpose of Review: Small non-coding RNAs regulate gene expression and are highly implicated in heart failure. Recently, an additional level of post-transcriptional regulation has been identified, referred to as the epitranscriptome, which encompasses the body of post-transcriptional modifications that are placed on RNA molecules. In this review, we summarize the current knowledge on the small non-coding RNA epitranscriptome in heart failure. Recent Findings: With the rise of new methods to study RNA modifications, epitranscriptome research has begun to take flight. Over the past 3 years, the number of publications on the epitranscriptome in heart failure has significantly increased, and we expect many more highly relevant publications to come out over the next few years. Summary: Currently, at least six modifications on small non-coding RNAs have been investigated in heart failure-relevant studies, namely N6-adenosine, N5-cytosine and N7-guanosine methylation, 2’-O-ribose-methylation, adenosine-to-inosine editing, and isomiRs. Their potential role in heart failure is discussed.

Original languageEnglish
JournalCurrent Heart Failure Reports
Volume19
Issue number5
Pages (from-to)255-266
Number of pages12
ISSN1546-9530
DOIs
Publication statusPublished - Oct 2022
Externally publishedYes

Bibliographical note

Publisher Copyright:
© 2022, The Author(s).

Keywords

  • Chemical modifications
  • Epitranscriptome
  • Heart failure
  • Post-transcriptional regulation
  • Small noncoding RNAs

Cite this